(Total Views: 547)
Posted On: 01/10/2021 10:53:43 PM
Post# of 153914
This is still confusing, (Cytodyn seeing s/c data) understandably so, since it is complex with alot of detail and acronyms and assumptions that we understand much of the technical langauage.
So Cytodyn can see some Secondary Endpoint data, and can deduce which data would probalby be from placebo folks and which data would probably be from Leronlimab folks, but it's still blinded because they don't know who these folks are, their names etc., I suppose?
Cytodyn cannot see Primary Endpoint "data", blood analysis data etc, but they are told about SAEs and death totals, but not death in placebo nor in leronlimab group. Nader told us of the 87 total deaths as of last week, which sparked massive speculation about how many were in LL and placebo groups, and subsequent numerous estimates on every CYDY discussion board of p values and Death Reduction Rates and EUA probabillties.
So Cytodyn can see some Secondary Endpoint data, and can deduce which data would probalby be from placebo folks and which data would probably be from Leronlimab folks, but it's still blinded because they don't know who these folks are, their names etc., I suppose?
Cytodyn cannot see Primary Endpoint "data", blood analysis data etc, but they are told about SAEs and death totals, but not death in placebo nor in leronlimab group. Nader told us of the 87 total deaths as of last week, which sparked massive speculation about how many were in LL and placebo groups, and subsequent numerous estimates on every CYDY discussion board of p values and Death Reduction Rates and EUA probabillties.
(1)
(0)
